These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37843204)

  • 1. Biochemical consequences of
    Yoon J; Lee CY; V Schapira AH
    Neural Regen Res; 2024 Apr; 19(4):725-727. PubMed ID: 37843204
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.
    Setó-Salvia N; Pagonabarraga J; Houlden H; Pascual-Sedano B; Dols-Icardo O; Tucci A; Paisán-Ruiz C; Campolongo A; Antón-Aguirre S; Martín I; Muñoz L; Bufill E; Vilageliu L; Grinberg D; Cozar M; Blesa R; Lleó A; Hardy J; Kulisevsky J; Clarimón J
    Mov Disord; 2012 Mar; 27(3):393-9. PubMed ID: 22173904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
    Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
    Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC; Krainc D
    Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson's Disease Patient Monocytes and Inversely Correlates with Motor Severity.
    Hughes LP; Pereira MMM; Hammond DA; Kwok JB; Halliday GM; Lewis SJG; Dzamko N
    J Parkinsons Dis; 2021; 11(3):1157-1165. PubMed ID: 33935104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.
    Balestrino R; Tunesi S; Tesei S; Lopiano L; Zecchinelli AL; Goldwurm S
    Mov Disord; 2020 Nov; 35(11):2111-2114. PubMed ID: 32767585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
    Mullin S; Stokholm MG; Hughes D; Mehta A; Parbo P; Hinz R; Pavese N; Brooks DJ; Schapira AHV
    Mov Disord; 2021 Mar; 36(3):774-779. PubMed ID: 33278043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood lysosphingolipids accumulation in patients with parkinson's disease with glucocerebrosidase 1 mutations.
    Pchelina S; Baydakova G; Nikolaev M; Senkevich K; Emelyanov A; Kopytova A; Miliukhina I; Yakimovskii A; Timofeeva A; Berkovich O; Fedotova E; Illarioshkin S; Zakharova E
    Mov Disord; 2018 Aug; 33(8):1325-1330. PubMed ID: 30192031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease Associated with GBA Gene Mutations: Molecular Aspects and Potential Treatment Approaches.
    Senkevich KA; Kopytova AE; Usenko TS; Emelyanov AK; Pchelina SN
    Acta Naturae; 2021; 13(2):70-78. PubMed ID: 34377557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
    N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase Mutations and Motor Reserve in Parkinson's Disease.
    Chung SJ; Lee PH; Sohn YH; Kim YJ
    J Parkinsons Dis; 2021; 11(4):1715-1724. PubMed ID: 34459414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucocerebrosidase mutations and uric acid levels in Parkinson's disease: A 3-years investigation of a potential biomarker".
    Mozafar M; Kazemian S; Hoseini E; Mohammadi M; Alimoghadam R; Shafie M; Mayeli M;
    Clin Park Relat Disord; 2023; 8():100177. PubMed ID: 36590455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.